Evidence map›Paper›PMID 38975712›Full record

ArticleApplied immunohistochemistry & molecular morphology : AIMM2024

Unusual PEComa With PRCC :: TFE3 Fusion Mimicking Sinonasal Tract Melanoma.

Jerzy Lasota, Lester D R Thompson, Małgorzata Chłopek, Artur Kowalik, Markku Miettinen

Abstract readCase Reports
In one paragraph

Article in Applied immunohistochemistry & molecular morphology : AIMM, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jerzy LasotaLaboratory of Pathology, National Cancer Institute, Bethesda, MD.
Lester D R ThompsonDepartment of Head and Neck Pathology, Woodland Hills, CA.
Małgorzata ChłopekLaboratory of Pathology, National Cancer Institute, Bethesda, MD.
Artur KowalikDepartment of Molecular Diagnostics, Holycross Cancer Center.
Markku MiettinenLaboratory of Pathology, National Cancer Institute, Bethesda, MD.

Funding

Immunohistochemical and genomic analysis of tumorsZIABC011427 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MIETTINEN, MARKKU · 2012 to 2025
$24.0M
Intramural NIH HHS ZIA BC011427
6 · The paper itself

Abstract

backgroundWe report a nasal cavity unusual perivascular epithelioid cell tumor (PEComa) mimicking mucosal melanoma.

methodsImmunohistochemistry was performed using BenchMark Ultra and panel of antibodies. The Ion Torrent platform and Ion AmpliSeq cancer hotspot panel were utilized for DNA genotyping. Target-specific RNA libraries for the detection of fusion transcripts were constructed using Archer Universal RNA Reagent Kit v2 and Archer FusionPlex Solid Tumor panel and sequenced on the MiSeqDx instrument.

resultsThe tumor, diagnosed in 46-year-old female, was composed of spindle cells, and lacked pigmentation. Immunohistochemically, it showed a patchy HMB-45 positivity. Other melanocytic markers (S100 protein, Melan-A, SOX10) were negative. The tumor cells were weakly positive for KIT (CD117) while negative for smooth muscle actin, pancytokeratin cocktail (AE1/AE3), and synaptophysin. Diagnosis of primary sinonasal tract mucosal melanoma was favored. Additional molecular studies detected PRCC :: TFE3 fusion as the sole genetic change, and suggested the diagnosis of unusual PEComa. Previously, TFE3 fusions were reported in a subset of PEComas but not in melanomas, while PRCC involvement has only been documented once in an ocular PEComa. Immunohistochemistry revealed strong nuclear TFE3 expression concordant with the molecular findings.

conclusionsThis report emphasis the importance of molecular testing in the differential diagnosis between PEComa and melanoma, especially when the tumor arises in a site typical of melanoma but showing an unusual morphology and immunophenotype. The detection of TFE3 fusion transcripts suggested the diagnosis of SNT PEComa, although it cannot be excluded that this and similar tumors represent a distinct diagnostic category.

Indexed as

Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsMelanomaPerivascular Epithelioid Cell NeoplasmsBiomarkers, TumorDiagnosis, DifferentialFemaleHumansImmunohistochemistryMiddle AgedNose NeoplasmsOncogene Proteins, FusionParanasal Sinus NeoplasmsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsBiomarkers, TumorOncogene Proteins, FusionTFE3 protein, human

Identifiers

PMID38975712
PMCPMC13410617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.